Kidney growth in children with congenital hypothyroidism

Mehmet Bülbül1, Semra Cetinkaya, Seçil Ekşioğlu

  • 1Department of Pediatric Nephrology, Sami Ulus Children's Hospital, Ankara, Turkey. mbbjkank@hotmail.com

Insights

Congenital hypothyroidism can impact kidney size in children. However, levothyroxine (L-thyroxine) treatment can lead to normal renal growth, even with delayed initiation or severe disease.

Area of Science:

  • Pediatric Endocrinology
  • Nephrology
  • Developmental Biology

Background:

  • Congenital hypothyroidism (CH) is a condition affecting thyroid hormone production in newborns.
  • The impact of CH and its treatment on renal growth in pediatric populations remains understudied.
  • Thyroid hormones play a crucial role in overall growth and development, including organogenesis.

Purpose of the Study:

  • To investigate the effect of congenital hypothyroidism and levothyroxine (L-thyroxine) treatment on kidney size in children.
  • To determine if delayed treatment initiation or severity of CH influences renal growth.
  • To explore the relationship between thyroid hormone levels and relative kidney volume.

Main Methods:

  • Prospective study including 40 children with CH and 37 healthy controls.
  • Assessment of anthropometric data (height, weight) and kidney dimensions (kidney length, total kidney volume).
  • Analysis of treatment parameters including age at L-thyroxine initiation and treatment duration, and correlation with kidney size and free thyroxine levels.

Main Results:

  • Children with CH exhibited smaller kidney length and total kidney volume compared to controls.
  • Kidney volume relative to body weight or height showed no significant difference between groups.
  • A positive correlation was observed between relative kidney volume and average free thyroxine levels.
  • No significant differences in kidney size were found based on age of L-thyroxine initiation or hypothyroidism severity.

Conclusions:

  • Normal renal growth is achievable with timely levothyroxine (L-thyroxine) replacement therapy in children with congenital hypothyroidism.
  • Considerable delays in treatment initiation or diagnosis of severe hypothyroidism do not preclude normal kidney development.
  • Maintaining adequate thyroid hormone levels is crucial for optimal renal growth in pediatric patients with CH.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...